Senna-s Tablet
NDC Package 70677-1069-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Senna-s (sennosides and docusate sodium) tablets is • If taking the starting dosage, take preferably at bedtime; or as directed by a doctor. This formulation utilizes a tablet delivery system. Marketed by Strategic Sourcing Services Llc, this product is identified by NDC 70677-1069 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
70677-1069-1
Package Description
1 BOTTLE in 1 CARTON / 60 TABLET in 1 BOTTLE
Product Code
70677-1069
11-Digit Billing Format
70677106901
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
  • RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
  • RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet

Clinical Specifications

Proprietary Name
Senna-s
Non-Proprietary Name
Sennosides And Docusate Sodium
Substance Name
Docusate Sodium; Sennosides
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
• If taking the starting dosage, take preferably at bedtime; or as directed by a doctor. • If taking the maximum dosage, take in the morning and at bedtime. AgeStarting DoseMaximum Doseadults and children 12 years of age and over2 tablets once a day4 tablets twice a daychildren 6 to under 12 years1 tablet once a day2 tablets twice a daychildren 2 to under 6 years1/2 tablet once a day2 tablets twice a daychildren under 2 yearsask a doctorask a doctor

Regulatory & Marketing

Labeler Name
Strategic Sourcing Services Llc
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-01-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70677-1069-1 identifies a specific commercial package of 1 bottle in 1 carton / 60 tablet in 1 bottle of Senna-s, a human over the counter drug labeled by Strategic Sourcing Services Llc. This tablet is formulated for oral use and contains docusate sodium; sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Strategic Sourcing Services Llc on May 01, 2023. The current certification is valid through December 31, 2026.

How is this Strategic Sourcing Services Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70677106901. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70677-1069-1
11-Digit CMS (5-4-2)
70677-1069-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.